| Name | L12_INTERNALSUBSTANCEDERM |
|---|---|
| Long name | Dermatitis due to substances taken internally |
| Hospital Discharge registry | ICD-10: L27, ICD-9: 693 |
| Hospital Discharge registry: exclude ICD-9 | L272 |
| Cause of Death registry | ICD-10: L27, ICD-9: 693 |
| Cause of Death registry: exclude ICD-9 | L272 |
| Level in the ICD-hierarchy | 3 |
| First defined in version | DF2 |
| Latin name | Dermatitis e substantiis devoratis |
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1181 | 752 | 429 |
| Unadjusted prevalence (%) | 0.54 | 0.61 | 0.46 |
| Mean age at first event (years) | 33.90 | 33.96 | 33.80 |
| Case fatality at 5-years (%) | 2.62 | 2.39 | 3.03 |
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | 1.0 |
| Recurrence at 6 months (%) | 23.45 | 23.80 | 22.84 |
before Dermatitis due to substances taken internally
after Dermatitis due to substances taken internally
Loading survival analyses plot…
Loading survival analyses table…